Krishna Vaddi Prelude Therapeutics Inc (PRLD) insider trading activity
Krishna Vaddi is CEO of Prelude Therapeutics Inc. Currently has a direct ownership of 2 Million shares of PRLD, which is worth approximately $1.38 Million. The most recent transaction as insider was on Mar 25, 2025, when has been sold 675,000 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $465,749. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2M
71.28%
3M change
87.33%
12M change
Total Value Held
$1.38 Million
Krishna Vaddi Transaction History
KV
Krishna Vaddi
CEO
Wilmington, DE